Anticancer activity of sesquiterpenoids extracted from Solanum lyratum via the induction of mitochondria-mediated apoptosis
Sesquiterpenoids are a major type of compound found in Solanum lyratum (S. lyratum). The present study aimed to investigate whether sesquiterpenoids from S. lyratum demonstrated cytotoxicity against the MCF-7, HCT-8, A-549, SGC-7901 and BEL-7402 cell lines, and the mechanism of solajiangxin H and lyratol D, which exhibited high cytotoxicity against SGC-7901 cells (half maximal inhibitory concentration, IC50=4.8 and 5.9 µg/ml), was associated with mitochondria-mediated apoptosis. The results of the Cell Counting Kit-8 assay indicated that 15 sesquiterpenoids had cytotoxicity against the aforementioned cultured cells. The results of DAPI staining and western blot analysis, used to study the anticancer mechanisms of solajiangxin H and lyratol D in SGC-7901 cells, suggested that solajiangxin H and lyratol D induced the apoptosis of SGC-7901 cells significantly (P<0.01), downregulated the expression of the antiapoptotic proteins B-cell lymphoma (Bcl)-2 and survivin, and upregulated the expression of the proapoptotic proteins Bcl-2-like protein 4, second mitochondria-derived activator of caspase, cleaved (c)-caspase-3 and c-caspase-9. The present study therefore demonstrated that 15 sesquiterpenoids from S. lyratum exhibited anticancer activity in MCF-7, HCT-8, A-549, SGC-7901 and BEL-7402 cells, and that the anticancer mechanisms of solajiangxin H and lyratol D may be associated with mitochondria-mediated apoptosis. Additionally, the present study provides evidence in support of the hypothesis that S. lyratum may be a promising candidate for the development of novel cancer therapies.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2017 |
---|---|
Erschienen: |
2017 |
Enthalten in: |
Zur Gesamtaufnahme - volume:13 |
---|---|
Enthalten in: |
Oncology letters - 13(2017), 1 vom: 26. Jan., Seite 370-376 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Chen, Min [VerfasserIn] |
---|
Links: |
---|
Themen: |
Anticancer activity |
---|
Anmerkungen: |
Date Revised 01.10.2020 published: Print-Electronic Citation Status PubMed-not-MEDLINE |
---|
doi: |
10.3892/ol.2016.5404 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM26834650X |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM26834650X | ||
003 | DE-627 | ||
005 | 20231224222504.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231224s2017 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.3892/ol.2016.5404 |2 doi | |
028 | 5 | 2 | |a pubmed24n0894.xml |
035 | |a (DE-627)NLM26834650X | ||
035 | |a (NLM)28123569 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Chen, Min |e verfasserin |4 aut | |
245 | 1 | 0 | |a Anticancer activity of sesquiterpenoids extracted from Solanum lyratum via the induction of mitochondria-mediated apoptosis |
264 | 1 | |c 2017 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Revised 01.10.2020 | ||
500 | |a published: Print-Electronic | ||
500 | |a Citation Status PubMed-not-MEDLINE | ||
520 | |a Sesquiterpenoids are a major type of compound found in Solanum lyratum (S. lyratum). The present study aimed to investigate whether sesquiterpenoids from S. lyratum demonstrated cytotoxicity against the MCF-7, HCT-8, A-549, SGC-7901 and BEL-7402 cell lines, and the mechanism of solajiangxin H and lyratol D, which exhibited high cytotoxicity against SGC-7901 cells (half maximal inhibitory concentration, IC50=4.8 and 5.9 µg/ml), was associated with mitochondria-mediated apoptosis. The results of the Cell Counting Kit-8 assay indicated that 15 sesquiterpenoids had cytotoxicity against the aforementioned cultured cells. The results of DAPI staining and western blot analysis, used to study the anticancer mechanisms of solajiangxin H and lyratol D in SGC-7901 cells, suggested that solajiangxin H and lyratol D induced the apoptosis of SGC-7901 cells significantly (P<0.01), downregulated the expression of the antiapoptotic proteins B-cell lymphoma (Bcl)-2 and survivin, and upregulated the expression of the proapoptotic proteins Bcl-2-like protein 4, second mitochondria-derived activator of caspase, cleaved (c)-caspase-3 and c-caspase-9. The present study therefore demonstrated that 15 sesquiterpenoids from S. lyratum exhibited anticancer activity in MCF-7, HCT-8, A-549, SGC-7901 and BEL-7402 cells, and that the anticancer mechanisms of solajiangxin H and lyratol D may be associated with mitochondria-mediated apoptosis. Additionally, the present study provides evidence in support of the hypothesis that S. lyratum may be a promising candidate for the development of novel cancer therapies | ||
650 | 4 | |a Journal Article | |
650 | 4 | |a Solanum lyratum | |
650 | 4 | |a anticancer activity | |
650 | 4 | |a apoptosis | |
650 | 4 | |a lyratol D | |
650 | 4 | |a sesquiterpenoids | |
650 | 4 | |a solajiangxin H | |
700 | 1 | |a Wu, Jian |e verfasserin |4 aut | |
700 | 1 | |a Zhang, Xing-Xing |e verfasserin |4 aut | |
700 | 1 | |a Wang, Qiong |e verfasserin |4 aut | |
700 | 1 | |a Yan, Shi-Hai |e verfasserin |4 aut | |
700 | 1 | |a Wang, Hai-Dan |e verfasserin |4 aut | |
700 | 1 | |a Liu, Sheng-Lin |e verfasserin |4 aut | |
700 | 1 | |a Zou, Xi |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Oncology letters |d 2010 |g 13(2017), 1 vom: 26. Jan., Seite 370-376 |w (DE-627)NLM201171317 |x 1792-1082 |7 nnns |
773 | 1 | 8 | |g volume:13 |g year:2017 |g number:1 |g day:26 |g month:01 |g pages:370-376 |
856 | 4 | 0 | |u http://dx.doi.org/10.3892/ol.2016.5404 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 13 |j 2017 |e 1 |b 26 |c 01 |h 370-376 |